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Objectives. Our aim is evaluating the need for repeating tests for syphilis on pregnant women in the third trimester. Study design.
A single-center retrospective cohort study was performed on all women delivering 7/03–6/04. Results. During the study interval,
2244 women delivered at our hospital. Of those women having available records and attending at least one prenatal visit, 1940
(98.9%) were screened for syphilis at the ﬁrst prenatal visit. Of the 1627 women beginning prenatal care prior to 27 weeks and
delivering after 32 weeks, 1377 (84.6%) were rescreened in the third trimester. No cases of syphilis were identiﬁed with either the
initial (upper limit of 95% CI 0.24%) or repeat (upper limit of 95% CI 0.34%) screening. Conclusions. In our obstetric population,
syphilis is so uncommon that mandated prenatal screening on more than one occasion seems unjustiﬁed and laws requiring
repeated screening should be reevaluated.
Copyright © 2006 Rodney K. Edwards et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
The Centers for Disease Control and Prevention recommend
screening all pregnant women for Chlamydia trachomatis
infection and syphilis at the ﬁrst prenatal visit. Repeated
screening for these infections during the third trimester is
recommended for those women at increased risk for con-
tracting these infections. Screening for gonorrhea once or
twice during pregnancy is recommended for those women
at risk [1].
Most states have laws requiring that women undergo
screening for syphilis at least once during pregnancy. Nine
states, including Florida, have statutory requirements that
pregnant women undergo screening for syphilis both at the
ﬁrst visit and again in the third trimester [2]. At least in
Florida, there is no similar law requiring prenatal screening
either for gonorrhea or Chlamydia trachomatis infection.
Screening for sexually transmitted diseases (STD) during
pregnancy has been advocated as being cost-eﬀective as long
as the prevalence exceeds 1% [3]. The reported prevalence of
gonorrhea during pregnancy varies widely, with rates vary-
ing between 0 and 10%, depending on the risk status of pa-
tients [4–6]. The prevalence of Chlamydia trachomatis infec-
tionduringpregnancyishigherthanthatofgonorrhea[7,8].
Syphilis is the least common of the sexually transmitted in-
fections that are endemic to the United States. In 2003, cases
of primary and secondary syphilis occurred at a rate of 2.5
cases per 100000 population [9]. Since reaching a nadir in
1999, the number of cases has increased slightly over the past
few years. However, this increase has been conﬁned to men
who have sex with men [9].
We sought to evaluate the prevalence of syphilis in the
obstetric population delivering at Shands Hospital at the
University of Florida. By doing so, we wanted to evaluate
the utility of repeating screening tests for syphilis during the
third trimester.
MATERIAL AND METHODS
We performed a historical cohort analysis of all women de-
livering at Shands Hospital at the University of Florida from
1 July 2003 to 30 June 2004. For consideration of screen-
ing for syphilis at the ﬁrst prenatal visit, all women who at-
tended at least one prenatal visit were included. For consid-
eration of the utility of repeating the screening in the third
trimester, women were included in the cohort if they began
prenatal care prior to 27-weeks gestation and delivered af-
ter 32 weeks, so as to allow a minimum of 6 weeks between2 Infectious Diseases in Obstetrics and Gynecology
ﬁrst-visit testing and delivery. Screening for syphilis utilized
nontreponemal tests of serum samples conﬁrmed with tre-
ponemal tests. Screening for gonorrhea and Chlamydia tra-
chomatisinfectionusedacombined testofDNA probes from
cervical swab specimens. The exact types of tests and manu-
facturersvaried,dependingonthepayer-speciﬁedlaboratory
forspeciﬁcpatients.TheUniversityofFloridaHealthScience
Center Institutional Review Board approved the study.
Subjects meeting criteria for inclusion in the cohort were
identiﬁed from the delivery log maintained in the Labor
and Delivery Unit at Shands Hospital at the University of
Florida and from the database maintained by the Division of
Maternal-Fetal Medicine at the University of Florida. Medi-
cal record charts of these women were abstracted, and data
were entered into a relational database (Access 2000, Mi-
crosoftCorporation,Redmond,Wash).SASVersion9.0(SAS
Institute, Cary, NC) was utilized for statistical analysis.
Rates of screening for syphilis at the ﬁrst prenatal visit
and again in the third trimester were calculated. The preva-
lence of infection with 95% conﬁdence intervals (CIs) (mod-
iﬁed Wald method) was calculated. We anticipated that the
inclusion of one year of delivered patients would yield a
cohort of over 1000 patients undergoing repeated third-
trimesterscreening,allowing95%conﬁdenceintervalsofless
than 3%. The unpaired Student’s t test was used for contin-
uous data. Categorical data were analyzed with the uncor-
rected chi-square and Fisher’s exact tests as appropriate. All
tests of statistical signiﬁcance were two-tailed and utilized an
alpha of 0.05.
RESULTS
During the study interval, 2244 women delivered at our hos-
pital, and 2085 charts were available for review. Of the 1962
women who had at least one prenatal care visit, the mean age
was 25.8 (standard deviation (SD) = 6.3) years. Fifty seven
percent of women were white, 25% were black, and 18%
were of other ethnicities. Sixty two percent of women were
parous, 64% were unmarried, 75% had either government-
sponsored or “self-”payer status, and 18% reported a prior
history of at least one sexually transmitted infection (gon-
orrhea, Chlamydia, syphilis, genital herpes, trichomoniasis,
or HIV). The ﬁrst prenatal visit for these patients occurred
at a mean gestational age of 13.7( S D = 6.9) weeks. Of
the 1962 women who had at least one prenatal care visit,
1724 (87.9%) were screened for gonorrhea and Chlamydia
trachomatis infection at the ﬁrst prenatal care visit. Of these
women, 19 (1.1%) had gonorrhea and 107 (6.2%) had a
Chlamydia trachomatis infection.
Of the 1962 women who had at least one prenatal care
visit, 1940 (98.9%) were screened for syphilis at the ﬁrst pre-
natal care visit. No cases of syphilis were identiﬁed with this
initial screening (95% conﬁdence interval (CI) = 0,0.24%).
Ofthe1627womenbeginningprenatalcarepriorto27weeks
and delivering after 32 weeks, 1377 (84.6%) were screened in
the third trimester. Similar to the results of screening at the
ﬁrst prenatal visit, no cases of syphilis were identiﬁed with
third trimester screening (95% CI = 0,0.34%).
DISCUSSION
Our study is limited by its retrospective nature. Also, these
data are from a single center during a single year, and they
may not be generalizable to other obstetric populations.
However, the prevalence rates of gonorrhea and Chlamydia
trachomatis infection in our population are similar to those
in other high-risk clinic populations [10]. Therefore, we be-
lieve that it is unlikely that the prevalence of syphilis in our
population is signiﬁcantly lower than it would be in the ma-
jority of practice settings in the United States.
In this study, compliance with our state’s legal require-
ment for screening for syphilis at the ﬁrst visit was excel-
lent (98.9%). Others have reported similarly high ﬁrst-visit
screening rates for syphilis and for other tests that are in-
cluded in some sort of “prenatal battery” [11]. Compliance
with the legal requirement for repeating screening in the
thirdtrimesterwaslower(84.6%).Reasonsforthislowerrate
ofscreeningthanattheﬁrstvisitlikelyincludepatientrefusal
and provider apathy due to the rarity of the infection.
The primary goal of screening pregnant women for
syphilis is to prevent cases of congenital syphilis. Currently,
the total number of cases in the United States each year is ap-
proximately 400 [9]. As with the rate of syphilis in women,
the incidence of syphilis in newborns also is decreasing.
Syphilis disproportionately aﬀects those living in urban ar-
eas. Most counties in our state and others rarely report a case
of primary or secondary syphilis in adults, much less a case
of congenital syphilis.
Clearly, because of the untoward consequences of con-
genital syphilis, screening women once during pregnancy for
this infection is reasonable and well justiﬁed. However, we
believe that the statutory requirement, as currently exists in
Florida and 8 other states, to screen all women twice during
pregnancy for an infection that is as rare as syphilis currently
should be reevaluated.
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